These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 217300)

  • 1. Treatment of experimental herpesvirus infections with phosphonoformate and some comparisons with phosphonoacetate.
    Kern ER; Glasgow LA; Overall JC; Reno JM; Boezi JA
    Antimicrob Agents Chemother; 1978 Dec; 14(6):817-23. PubMed ID: 217300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effect of trisodium phosphonoformate on cutaneous herpesvirus infection in guinea pigs.
    Alenius S; Dinter Z; Oberg B
    Antimicrob Agents Chemother; 1978 Sep; 14(3):408-13. PubMed ID: 213015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of phosphonoacetic acid and phosphonoformic acid activity in genital herpes simplex virus type 1 and type 2 infections of mice.
    Kern ER; Richards JT; Overall JC; Glasgow LA
    Antiviral Res; 1981 Nov; 1(4):225-35. PubMed ID: 6280607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of mortality and pathogenesis of three experimental Herpesvirus hominis infections of mice with adenine arabinoside 5'-monophosphate, adenine arabinoside, and phosphonoacetic acid.
    Kern ER; Richards JT; Overall JC; Glasgow LA
    Antimicrob Agents Chemother; 1978 Jan; 13(1):53-60. PubMed ID: 204250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of phosphonoformate on symptomatic genital herpes simplex virus type 2 infection of guinea pigs.
    Mayo DR; Lucia HL; Hsiung GD
    Intervirology; 1983; 19(1):26-32. PubMed ID: 6298142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical phosphonoacetic acid treatment of cutaneous herpes simplex infections in the guinea pig.
    McCarty JR; Jarratt MT
    J Am Acad Dermatol; 1979 Sep; 1(3):244-8. PubMed ID: 512074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental studies on the antiherpetic agent phosphonoformic acid.
    Helgstrand E; Oberg B; Alenius S
    Adv Ophthalmol; 1979; 38():276-80. PubMed ID: 230720
    [No Abstract]   [Full Text] [Related]  

  • 8. Latent infections of sensory ganglia as influenced by phosphonoformate treatment of herpes simplex virus-induced skin infections in hairless mice.
    Klein RJ; DeStefano E; Brady E; Friedman-Kien AE
    Antimicrob Agents Chemother; 1979 Sep; 16(3):266-70. PubMed ID: 507784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-herpesvirus activity of adenine arabinoside analogues in tissue culture and a genital infection of mice and guinea pigs.
    Richards JT; Kern ER; Overall JC; Glasgow LA
    Antiviral Res; 1982 May; 2(1-2):27-39. PubMed ID: 6179469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trisodium phosphonoformate, a new antiviral compound.
    Helgstrand E; Eriksson B; Johansson NG; Lannerö B; Larsson A; Misiorny A; Norén JO; Sjöberg B; Stenberg K; Stening G; Stridh S; Oberg B
    Science; 1978 Sep; 201(4358):819-21. PubMed ID: 210500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of herpesvirus multiplication in guinea pig skin by antiviral compounds.
    Alenius S
    Arch Virol; 1980; 65(2):149-56. PubMed ID: 6252867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes simplex virus hepatitis in mice: effects of treatment with trisodium phosphonoformate.
    Ulbricht A; Färber I; Wutzler P
    Acta Virol; 1985 Dec; 29(6):493-8. PubMed ID: 2869661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracerebroventricular and intraperitoneal disodium phosphonoacetate treatment of herpes simplex virus type I experimental encephalitis in rats.
    Aoki FY; Trépanier G; Lussier G
    J Infect Dis; 1979 Feb; 139(2):158-65. PubMed ID: 220332
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessment of phosphonoformate-treatment of pigeon herpesvirus infection in pigeons and budgerigars and Aujeszky's disease in rabbits.
    Vindevogel H; Pastoret PP; Aguilar-Setien A
    J Comp Pathol; 1982 Apr; 92(2):177-80. PubMed ID: 6282943
    [No Abstract]   [Full Text] [Related]  

  • 15. Phosphonoacetic acid effective in herpesvirus infection.
    Diosi P; Georgescu L; Ciuhandu G; Plavoşin L
    Virologie; 1982; 33(1):73-4. PubMed ID: 6280376
    [No Abstract]   [Full Text] [Related]  

  • 16. Mode of action of phosphonoformate as an anti-herpes simplex virus agent.
    Cheng YC; Grill S; Derse D; Chen JY; Caradonna SJ; Connor K
    Biochim Biophys Acta; 1981 Jan; 652(1):90-8. PubMed ID: 6260189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of herpesvirus replication and herpesvirus-induced deoxyribonucleic acid polymerase by phosphonoformate.
    Reno JM; Lee LF; Boezi JA
    Antimicrob Agents Chemother; 1978 Feb; 13(2):188-92. PubMed ID: 206200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical treatment of recurrent genital herpes simplex virus infections with trisodium phosphonoformate (foscarnet): double blind, placebo controlled, multicentre study.
    Barton SE; Munday PE; Kinghorn GR; van der Meijden WI; Stolz E; Notowicz A; Rashid S; Schuller JL; Essex-Cater AJ; Kuijpers MH
    Genitourin Med; 1986 Aug; 62(4):247-50. PubMed ID: 2942457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of herpesvirus mutants resistant to phosphonoformate and phosphonoacetate.
    Eriksson B; Oberg B
    Antimicrob Agents Chemother; 1979 Jun; 15(6):758-62. PubMed ID: 475360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of trisodium phosphonoformate in genital infection of female guinea pigs with herpes simplex virus type 2.
    Alenius S; Nordlinder H
    Arch Virol; 1979; 60(3-4):197-206. PubMed ID: 508093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.